Technetium-99m-Tetrofosmin Whole-Body Scintigraphy in the Follow-up of Differentiated Thyroid Carcinoma

Peter Lind; Hans J. Gallowitsch; Werner Langsteger; Ewald Kresnik; Peter Mikosch; Iris Gomez

Research ArticleNuclear Oncology

Technetium-99m-Tetrofosmin Whole-Body Scintigraphy in the Follow-up of Differentiated Thyroid Carcinoma

Peter Lind, Hans J. Gallowitsch, Werner Langsteger, Ewald Kresnik, Peter Mikosch and Iris Gomez

Journal of Nuclear Medicine March 1997, 38 (3) 348-352;

Peter Lind

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hans J. Gallowitsch

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Werner Langsteger

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ewald Kresnik

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter Mikosch

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Iris Gomez

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 38, Issue 3

March 1, 1997

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Technetium-99m-Tetrofosmin Whole-Body Scintigraphy in the Follow-up of Differentiated Thyroid Carcinoma

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Technetium-99m-Tetrofosmin Whole-Body Scintigraphy in the Follow-up of Differentiated Thyroid Carcinoma

Peter Lind, Hans J. Gallowitsch, Werner Langsteger, Ewald Kresnik, Peter Mikosch, Iris Gomez

Journal of Nuclear Medicine Mar 1997, 38 (3) 348-352;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Technetium-99m-Tetrofosmin Whole-Body Scintigraphy in the Follow-up of Differentiated Thyroid Carcinoma

Peter Lind, Hans J. Gallowitsch, Werner Langsteger, Ewald Kresnik, Peter Mikosch, Iris Gomez

Journal of Nuclear Medicine Mar 1997, 38 (3) 348-352;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Effect of Asiaticoside on 99mTc-Tetrofosmin and 99mTc-Sestamibi Uptake in MCF-7 Cells
131I SPECT/CT in the Follow-up of Differentiated Thyroid Carcinoma: Incremental Value Versus Planar Imaging
PET in the follow-up of differentiated thyroid cancer
The thyroid gland
Advances in radionuclide imaging: radionuclide imaging as a guide to therapy

Google Scholar

Main menu

User menu

Search

Technetium-99m-Tetrofosmin Whole-Body Scintigraphy in the Follow-up of Differentiated Thyroid Carcinoma

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles